Chief Financial Officer · Protara Therapeutics, Inc. (TARA)

Patrick Fabbio

A named executive officer of Protara Therapeutics in every fiscal year CompBrief holds from FY2023 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,023,536

Salary $464,967Stock awards $42,020

FY2023: $1,443,529

4th of 4 named executive officers at Protara Therapeutics by FY2024 total.

4 named officers on file for Protara Therapeutics, FY2024

Patrick Fabbio’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Protara Therapeutics’s whole pay program stands against its peers

  • Protara Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TARA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2025 (DEF 14A).

Free

Get Patrick Fabbio’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Patrick Fabbio compensation by year

Protara Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Protara Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024
Salary$412,875$464,967
Bonus$25,000$0
Stock awards$0$42,020
Option awards$746,910$199,107
Non-equity incentive$206,758$260,325
Pension and deferred compensation$0$0
All other$51,986$57,117
Total$1,443,529$1,023,536

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Protara Therapeutics, Inc. DEF 14A filed April 25, 2025, accession 0001213900-25-035568, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Protara Therapeutics, Inc. filed document, accession 0001213900-25-035568. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2025.

$1.4M
$1.0M
FY23
FY24
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU22,000$116,160—
Option156,250—$3.14
Option131,000—$1.91

Per the Outstanding Equity Awards at Fiscal Year-End table in Protara Therapeutics, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Protara Therapeutics’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Jesse SheffermanPresident, Chief Executive Officer and Director$1,791,843
Jacqueline ZummoChief Scientific Operations Officer$1,214,189
Jathin BandariFormer Chief Medical Officer$1,081,276
Patrick Fabbio · this pageChief Financial Officer$1,023,536

The full Protara Therapeutics compensation record

free company brief

This page is one person within Protara Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Protara Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Patrick Fabbio's compensation dossier · One-time report. No refunds.